Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Drug discovery

Research Field Analytical science

Carving Out an Analytical Niche

| Joanna Cummings

Renã Robinson, Assistant Professor, University of Pittsburgh, Pennsylvania, USA

Research Field Animal models

Skin in the Game

| William Aryitey

Could donated human skin provide a viable alternative to animal testing?

Research Field Genetics

Kallikrein Dream

| Roisin McGuigan

Eleftherios P. Diamandis, Hold ’em for Life Chair in Prostate Cancer Biomarkers, University of Toronto.

Tools & Techniques Drug discovery

Escaping the Rat Race

| Stefan Amisten

Over-reliance on rodent models could be leading drug discovery in the wrong direction

Research Field Respiratory

A Breath of Fresh Air?

| Roisin McGuigan

Regulating the production of alpha-synuclein may be a new approach for treating Parkinson’s

Research Field Cancer

Leidenfrost Nanochemistry

| James Strachan

Scientists fabricate anticancer nanoparticles by recreating deep sea volcano chemistry.

Disease Area Drug discovery

Targeting Tuberculosis

| Santiago Ramón-García

Existing drugs can – and should – be repurposed to fight neglected diseases.

Research Field Omics

Embracing the Proteogenomic Toolkit

| Andreas Hühmer

To win the war on cancer, we need to put proteomics on an equal footing with genomics.

Tools & Techniques Cancer

Cracking Cancer’s Code

| Roisin McGuigan

Sitting Down With George Calin, Professor, The University of Texas MD Anderson Cancer Center, USA.

Research Field Drug discovery

Here Be Dragons

| Rich Whitworth

Antimicrobial peptides found in Komodo dragon plasma provide inspiration for new antibiotics.

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register